Appoints new board members with extensive biotech and pharma experience
VANCOUVER, BC, April 25, 2023 /CNW/ – Kapoose Creek Wellness today announced a sharpened strategic focus on drug discovery and development, along with the appointment of three outstanding new directors to support the company’s growth in the sector. Reflecting this commitment, the company is changing its name to Kapoose Creek Bio.
“Kapoose Creek’s over-arching value proposition is that the next generation of medicines have existed all this time, hidden in nature, in undiscovered fungal chemistry. Working in partnership with McMaster University, we have developed a platform that revolutionizes drug discovery from nature. We couldn’t be more excited about our potential, or the results we’ve achieved to date,” said Dr. Eric Brown, CEO, Kapoose Creek Bio.
The company’s new directors bring decades of experience in biotech, pharma and venture capital to the Kapoose Creek Board, where they join Brown, and Board Chair Sam Feldman. They include:
